Summary Background The LIR! C trial showed that laparoscopic ileocaecal resection is a
cost-effective treatment that has similar quality-of-life outcomes to treatment with infliximab …

Background Treatment of patients with ileocaecal Crohn's disease who have not responded
to conventional therapy is commonly scaled up to biological agents, but surgery can also …

Objective Evaluate the cost-effectiveness of laparoscopic ileocaecal resection compared
with infliximab in patients with ileocaecal Crohn's disease failing conventional therapy …

Background & Aims Most patients with Crohn's disease (CD) eventually require an intestinal
resection. However, CD frequently recurs after resection. We performed a randomized trial to …

BACKGROUND: The purpose of this study was to analyze long-term recurrence rates and
complications in patients previously enrolled in a prospective randomized trial comparing …

Aim Studies to date examining the impact of laparoscopy in resection for Crohn's disease on
short‐term morbidity have been limited by small study populations. The aim of this study was …

Background Surgical resection is almost inevitable in Crohn's disease. Surgery is usually
performed for refractory or complicated disease: no studies appear to have been carried out …

Background The efficacy of infliximab for endoscopic recurrence after resection of Crohn's
disease (CD) has not yet been reported. The aim of this prospective study was to investigate …

PURPOSE: Elective laparoscopic-assisted resection of terminal ileal Crohn's disease is
slowly gaining acceptance as an alternative to conventional surgery, based on the …

Background & Aims Early Crohn's disease (CD) treatment involves anti-tumor necrosis factor
(TNF) agents, whereas ileocecal resection (ICR) is reserved for complicated CD or treatment …